Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 8, 2024
Reporting Period: Specific event date of February 8, 2024.
Key Financial Metrics
This filing does not contain financial performance data. The document does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing reports material changes to the composition and leadership of the Board of Directors following the previously disclosed retirement and resignation of Dennis Meteny:
- Audit Committee: Wesley Johnson appointed as new chair.
- Nominating, Compliance and Corporate Governance Committee: Jan Stern Reed appointed as new chair.
- Director Class Rebalancing: James Clemmer resigned as a Class II director and was immediately re-appointed as a Class I director. This action was taken solely to rebalance the Board classes to approximately one-third each, with his term expiring at the 2025 Annual Meeting of Stockholders. His service is deemed uninterrupted.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The document is strictly limited to corporate governance updates.
Investor Verification Checklist
- Verify the effective date of the new committee chair appointments (February 8, 2024).
- Confirm the updated term expiration for James Clemmer (2025 Annual Meeting).
- Review the prior Form 8-K filed on January 22, 2024, for details regarding Dennis Meteny's retirement.